• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Activity of Delpazolid and Comparator Agents Against Methicillin-resistant Involved in Bloodstream Infection.

作者信息

Park Jeong Su, Choi Yun Jung, Kwon Kyungmi, Choi Seong Jin, Moon Song Mi, Song Kyoung-Ho, Kim Eu Suk, Park Kyoung Un, Kim Hong Bin

机构信息

Department of Laboratory Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

出版信息

Ann Lab Med. 2023 Jul 1;43(4):389-391. doi: 10.3343/alm.2023.43.4.389. Epub 2023 Feb 24.

DOI:10.3343/alm.2023.43.4.389
PMID:36843409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9989538/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f7/9989538/3f293fae7e99/alm-43-4-389-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f7/9989538/3f293fae7e99/alm-43-4-389-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58f7/9989538/3f293fae7e99/alm-43-4-389-f1.jpg

相似文献

1
Activity of Delpazolid and Comparator Agents Against Methicillin-resistant Involved in Bloodstream Infection.达帕唑胺及对照药物对耐甲氧西林金黄色葡萄球菌血流感染的活性
Ann Lab Med. 2023 Jul 1;43(4):389-391. doi: 10.3343/alm.2023.43.4.389. Epub 2023 Feb 24.
2
Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium.利奈唑胺与其他五种抗菌药物对耐甲氧西林金黄色葡萄球菌、耐甲氧西林表皮葡萄球菌和耐万古霉素粪肠球菌医院分离株的体外活性比较
J Chemother. 2003 Oct;15(5):442-8. doi: 10.1179/joc.2003.15.5.442.
3
Comparative activities of TR-700 (torezolid) against staphylococcal blood isolates collected in Spain.西班牙采集的葡萄球菌血分离株的 TR-700（替考拉宁）比较活性。
Antimicrob Agents Chemother. 2010 May;54(5):2212-5. doi: 10.1128/AAC.01653-09. Epub 2010 Feb 22.
4
Comparison of in vitro efficacy of linezolid and vancomycin by determining their minimum inhibitory concentrations against methicillin resistant Staphylococcus aureus (MRSA).通过测定利奈唑胺和万古霉素对耐甲氧西林金黄色葡萄球菌（MRSA）的最低抑菌浓度来比较二者的体外疗效。
J Pak Med Assoc. 2011 Apr;61(4):356-9.
5
Comparative Efficacy of Ceftaroline with Linezolid against Staphylococcus aureus and Methicillin Resistant Staphylococcus aureus.头孢洛林与利奈唑胺对金黄色葡萄球菌和耐甲氧西林金黄色葡萄球菌的疗效比较
J Coll Physicians Surg Pak. 2015 Apr;25(4):247-9.
6
Activity of ceftaroline against community associated and healthcare associated methicillin resistant Staphylococcus aureus.
Pathology. 2014 Jan;46(1):71-3. doi: 10.1097/PAT.0000000000000032.
7
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.替考拉宁对当代全球范围内金黄色葡萄球菌分离株的体外活性研究。
Antimicrob Agents Chemother. 2010 Jun;54(6):2704-6. doi: 10.1128/AAC.00301-10. Epub 2010 Apr 12.
8
In vitro activity of linezolid against clinical isolates of methicillin resistant Staphylococcus.利奈唑胺对耐甲氧西林葡萄球菌临床分离株的体外活性
J Ayub Med Coll Abbottabad. 2009 Jan-Mar;21(1):106-9.
9
In vivo pharmacodynamics of torezolid phosphate (TR-701), a new oxazolidinone antibiotic, against methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains in a mouse thigh infection model.在一种小鼠大腿感染模型中，研究了新型噁唑烷酮类抗生素磷酸托唑烷（TR-701）对甲氧西林敏感和耐药金黄色葡萄球菌菌株的体内药效学。
Antimicrob Agents Chemother. 2011 Jul;55(7):3453-60. doi: 10.1128/AAC.01565-10. Epub 2011 Apr 18.
10
Trends in antimicrobial susceptibility patterns in healthcare-associated methicillin-resistant from bloodstream infections: A joinpoint regression analysis.
Infect Control Hosp Epidemiol. 2022 Dec;43(12):1955-1957. doi: 10.1017/ice.2021.448. Epub 2021 Nov 2.

引用本文的文献

1
Staph wars: the antibiotic pipeline strikes back.葡萄球菌之战：抗生素管道奋起反击。
Microbiology (Reading). 2023 Sep;169(9). doi: 10.1099/mic.0.001387.

本文引用的文献

1
Overview of Changes to the Clinical and Laboratory Standards Institute M100, 31st Edition.临床和实验室标准协会 M100，31 版更改概述。
J Clin Microbiol. 2021 Nov 18;59(12):e0021321. doi: 10.1128/JCM.00213-21. Epub 2021 Sep 22.
2
Ten-Year Prevalence Trends of Phenotypically Identified Community-Associated Methicillin-Resistant Strains in Clinical Specimens.表型鉴定的社区相关性耐甲氧西林金黄色葡萄球菌在临床标本中的十年流行趋势。
Ann Lab Med. 2021 Jul 1;41(4):386-393. doi: 10.3343/alm.2021.41.4.386.
3
Multiple-dose Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral LCB01-0371 in Healthy Male Volunteers.
口服 LCB01-0371 在健康男性志愿者中的多次给药安全性、耐受性、药代动力学和药效学。
Clin Ther. 2018 Dec;40(12):2050-2064. doi: 10.1016/j.clinthera.2018.10.007. Epub 2018 Nov 10.
4
Treatment strategies for persistent methicillin-resistant Staphylococcus aureus bacteraemia.持续性耐甲氧西林金黄色葡萄球菌菌血症的治疗策略
J Clin Pharm Ther. 2018 Oct;43(5):614-625. doi: 10.1111/jcpt.12743. Epub 2018 Jul 12.
5
Comparison of Activity and MIC Distributions between the Novel Oxazolidinone Delpazolid and Linezolid against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis in China.比较新型恶唑烷酮类药物 delpazolid 与利奈唑胺对中国耐多药和广泛耐药结核分枝杆菌的活性和 MIC 分布。
Antimicrob Agents Chemother. 2018 Jul 27;62(8). doi: 10.1128/AAC.00165-18. Print 2018 Aug.
6
In vitro and in vivo activities of LCB01-0371, a new oxazolidinone.新型恶唑烷酮类药物 LCB01-0371 的体外和体内活性研究。
Antimicrob Agents Chemother. 2010 Dec;54(12):5359-62. doi: 10.1128/AAC.00723-10. Epub 2010 Sep 20.
7
Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.耐甲氧西林金黄色葡萄球菌对糖肽类、达托霉素和利奈唑胺的耐药性或敏感性降低。
Curr Opin Pharmacol. 2010 Oct;10(5):516-21. doi: 10.1016/j.coph.2010.06.006. Epub 2010 Jul 1.
8
Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome.利奈唑胺相关的周围神经和视神经病变、乳酸性酸中毒及5-羟色胺综合征。
Pharmacotherapy. 2007 Aug;27(8):1189-97. doi: 10.1592/phco.27.8.1189.